Andres Juan's Form 4 filing
Moderna, Inc. (MRNA) · filed Oct 26, 2021
- Accession no.
- 0001127602-21-027654
- Filed
- Oct 26, 2021
- Trade date
- Oct 22-25, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $6.58M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andres JuanCIK 0001760670 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 | Common Stock | MOption exerciseAcquired | +5,000 | $12.21 | +$61,050 | 5,000 | Direct | |
| Oct 22, 2021 | Common Stock | SSaleDisposed | −5,000 | $333.00 | −$1,665,000 | 0 | Direct | |
| Oct 25, 2021 | Common Stock | MOption exerciseAcquired | +178 | $14.22 | +$2,531.16 | 178 | Direct | |
| Oct 25, 2021 | Common Stock | MOption exerciseAcquired | +5,000 | $12.21 | +$61,050 | 5,178 | Direct | |
| Oct 25, 2021 | Common Stock | MOption exerciseAcquired | +9,822 | $12.21 | +$119,926.62 | 15,000 | Direct | |
| Oct 25, 2021 | Common Stock | SSaleDisposed | −15,000 | $327.36 | −$4,910,400 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 159,822 | Direct | |
| Oct 25, 2021 | Common Stock | MOption exerciseDisposed | −178 | $0.00 | $0 | 68,629 | Direct | |
| Oct 25, 2021 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 154,822 | Direct | |
| Oct 25, 2021 | Common Stock | MOption exerciseDisposed | −9,822 | $0.00 | $0 | 145,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Chief Technical Operations and Quality Officer